Arkolith/Insider Trading/BIXT/Form 4

Chen-Walden Hana

DirectorBIOXYTRAN, INC (BIXT) · full profile →Form 4 · filed May 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 18, 2023Grant(A)20K$0.48$10K368K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2023Expiration(H)3K$0.25$7506K

Transaction Codes

A
Grant / award
H
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001445815-23-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML